Aigh Capital Management LLC Aridis Pharmaceuticals, Inc. Transaction History

Aigh Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$2.0 - $3.65 $301,182 - $549,657	-150,591 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.55 - $7.49 $1.1 Million - $2.31 Million	-308,670 Reduced 67.21%	150,591 $554,000
Q2 2021 Aug 12, 2021	BUY	$5.3 - $7.4 $190,291 - $265,689	35,904 Added 8.48%	459,261 $3.33 Million
Q1 2021 May 13, 2021	BUY	$5.54 - $8.1 $422,929 - $618,362	76,341 Added 22.0%	423,357 $2.5 Million
Q4 2020 Feb 16, 2021	BUY	$6.07 - $8.01 $2.11 Million - $2.78 Million	347,016 New	347,016 $2.11 Million

50.2K

Ticker ARDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,701,600
Description
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.